Meet Entourage
in Amsterdam
Strategic conversations on biosimilar access, EU pharmaceutical policy, and market dynamics.
Your Strategic Partner
for the Biosimilar Lifecycle.
While the Biosimilar Medicines Conference sets the agenda for access and policy, translating these discussions into operational reality requires a partner who understands both strategy and execution. Entourage is the leading hybrid consultancy supporting biosimilar manufacturers from regulatory approval through to resilient commercialisation.
Regulatory Strategy & Compliance Excellence
We guide you through the evolving EU regulatory landscape—ensuring inspection readiness and rapid, compliant biosimilar approval pathways.
Commercialisation & Market Access
Leverage our strategic frameworks to optimize payer engagement, navigate local HTA processes, and accelerate sustainable market entry.
Resilient Supply Chains & Manufacturing
Our operational experts help you build robust manufacturing networks, de-risk global supply chains, and overcome scaling bottlenecks.
The "Hybrid Consulting" Advantage
We don't just advise—we execute. Our unique blend of management consulting and deep life-science specialization delivers measurable results on the ground.
A Powerful European Network
Benefit from our deep relationships across the European life science sector to build the alliances necessary to unlock the full potential of your pipeline.
Contact
Do you have any questions or would you like to book a meeting at the conference? Write to us directly.
Your Contacts on-site:
Moritz Haucke
Managing Partner
Lena Pauli
Principal Consultant